Universität Bonn

Pharma-Zentrum Bonn

de
Matthias Geyer
© K. Wislsperger
Prof. Dr. rer. nat. Matthias Geyer
Faculty of Medicine

Webseite

Zugehörigkeiten
  • Institute of Structural Biology
Forschungsschwerpunkte
  • inflammasone
  • transcriptional CDK
  • structural biology
We are interested in the molecular mechanisms that govern immune receptor activation and the regulation of transcription. We use a variety of techniques from molecular biology and biochemistry to structural biology to determine protein–protein interactions as well as the interaction to lipids, model membranes, nucleic acids, and small molecular ligands. Understanding cellular regulation at a molecular level is the key interest of our research.
Ausgewählte Publikationen

Hochheiser IV, Behrmann H, Hagelueken G, Rodríguez-Alcázar JF, Kopp A, Latz E, Behrmann E, Geyer M (2022.) Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation. Science Advances 8, eabn7583.

Hochheiser IV, Pilsl M, Hagelueken G, Moecking J, Marleaux M, Brinkschulte R, Latz E, Engel C, Geyer M (2022). Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604, 184–189.

Kaltheuner IH, Anand K, Moecking J, Düster R, Wang J, Gray NS, Geyer M (2021). Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. Nat. Commun. 12: 6607.

Eick D, Geyer M (2013). The RNA polymerase II carboxy-terminal domain (CTD) code. Chemical Reviews 113, 8456–8490.

Matthias Geyer
© K. Wislsperger
Prof. Dr. rer. nat. Matthias Geyer
Faculty of Medicine

Webseite

+49 228 287 51400